Start Date
January 31, 2022
Primary Completion Date
June 30, 2023
Study Completion Date
June 30, 2023
Valproic acid
Valproate sodium in 5-ml single-dose vials containing 100 mg/ml of VPA. The appropriate dose of 140 mg/kg, based on the subject's weight at study entry, will be diluted in isotonic saline solution to a final volume of 300 ml for administration
Isotonic saline solution
Isotonic saline solution consisting of 0.9% sodium chloride in the volume of 300 ml for administration
University of Texas Southwest, Dallas
Houston Methodist Specialty and Transplant Hospital, Houston
University of Colorado - Denver, Denver
University of California San Francisco, San Francisco
Lead Sponsor
Collaborators (1)
United States Department of Defense
FED
Clinipace Worldwide
INDUSTRY
Westat
OTHER